Silver Standard Resources Inc (SSRI) 4.82 $SSRI Who Will

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

MENU ORDER AI: The Future of Dining for GLP-1 Users As a unique health-tech application tailored for GLP-1 users, MENU ORDER AI is pioneering a dining revolution. Designed to assist both diners and restaurants, this amazing application utilizes AI to scan menus in real-time and provide nutritional insights. It empowers users to 'Eat anywhere. Order smarter.' Medicare...

Innovations in MPYS Protein Stimulants MPYS protein stimulants are making waves in the field of immunotherapy, revolutionizing the way we combat various diseases including cancers and autoimmune disorders. These stimulants activate the STING pathway, significantly enhancing the body’s innate immune response to infections and malignancies. With a growing demand for...

RoboUP Unveils the TM01 Series 2025: A New Era in Lawn Care As a prominent name in robotic lawn care technology, RoboUP has introduced its groundbreaking TM01 Series 2025 mower, aimed at addressing the commonly faced challenges in traditional lawn maintenance. With a focus on user-friendly features, RoboUP is setting a remarkable benchmark in the world of automated...

IMAX's Impressive Performance in 2025 While many investors have focused on the explosive growth of artificial intelligence stocks in 2025, one company in the entertainment technology arena has maintained remarkable performance, largely unnoticed. IMAX Corporation (NYSE: IMAX) has achieved significant returns, boasting an impressive year-to-date increase of over 41%. This...

Exciting Collaboration Between Northern Tool + Equipment and Monster Jam Northern Tool + Equipment is thrilled to bring the legendary Monster Jam experience to the Houston-area community. This special event will feature an iconic Monster Jam truck, providing fans with an opportunity to see the high-powered vehicle up close. Event Details and Exclusive Offers The...